Shandong Weigao will make the acquisition through a joint venture (JV) formed by its wholly owned subsidiary Weigao International and an undisclosed firm based in the Cayman Islands. Weigao International will hold a 90% share in the JV, while the unnamed firm will hold the remaining 10%.
The acquisition is part of Shandong Weigao’s overseas expansion strategy.
The acquisition will enable Bruker to expand its product portfolio.
The addition will enable Konica Minolta to expand it precision medicine business.
Private equity firm Avista Capital Partners plans to acquire clinical pathology services provider Miraca Life Sciences Inc from clinical diagnostics and laboratory testing service provider Miraca Holdings Inc.
The acquisition will support the expansion of Miraca Life Sciences’ business.
The purchase will allow the company to expand its business in the international market.